Breaking News Instant updates and real-time market news.

BCC

Boise Cascade

$29.22

0.2 (0.69%)

05:47
05/07/19
05/07
05:47
05/07/19
05:47

Boise Cascade reports Q1 EPS 29c, consensus 23c

Reports Q1 revenue $1.04B, consensus $1.11B.

  • 07

    May

BCC Boise Cascade
$29.22

0.2 (0.69%)

02/27/19
02/27/19
UPGRADE

Fly Intel: Top analyst upgrades
Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Philip Morris (PM) upgraded to Buy from Neutral at UBS with analyst Robert Rampton saying the company's valuation hinges on its heated tobacco proposition, iQOS. 2. Boise Cascade (BCC) upgraded to Buy from Neutral at DA Davidson with analyst Steven Chercover saying that with the "irrational exuberance" having been shaken out of the stock, now is an "attractive entry point." 3. AptarGroup (ATR) upgraded to Outperform from Neutral at Baird. 4. W. R. Berkley (WRB) upgraded to Outperform from Neutral at Credit Suisse, while Cincinnati Financial (CINF) was upgraded to Neutral from Underperform. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/27/19
DADA
02/27/19
UPGRADE
Target $37
DADA
Buy
Boise Cascade upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Steven Chercover upgraded Boise Cascade to Buy and raised his price target to $37 from $35, saying that with the "irrational exuberance" having been shaken out of the stock, now is an "attractive entry point". The analyst cites the positive "risk-reward outlook on the commodity front, the stability of the distribution business, the balance sheet, and the esteem" in which he holds the management. Based on its recent dividend payouts, Chercover adds that the management is positioned to "deliver value in any commodity pricing / demand environment."
02/27/19
DADA
02/27/19
UPGRADE
DADA
Buy
Boise Cascade upgraded to Buy from Neutral at DA Davidson
11/07/18
DADA
11/07/18
NO CHANGE
Target $35
DADA
Neutral
Boise Cascade price target lowered to $35 from $45 at DA Davidson
DA Davidson analyst Steven Chercover lowered his price target on Boise Cascade to $35 and kept his Neutral rating, while also reducing his FY18 EPS view to $2.20 from $3.22 and FY19 to $2.04 from $2.91 after its Q3 earnings miss. The analyst notes that although commodity prices may rebound, he is still reluctant to get more constructive on the stock in spite of its 40% decline from this year's high. Chercover adds that Boise Cascade's sale of Oregon facilities and curtailment of Roxboro LVL production speak to its strategic focus of contained capacity.

TODAY'S FREE FLY STORIES

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

18:39
05/22/19
05/22
18:39
05/22/19
18:39
Periodicals
Breaking Periodicals news story on Daiichi Sankyo »

Daiichi Sankyo in talks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SPOT

Spotify

$127.10

-5.06 (-3.83%)

18:27
05/22/19
05/22
18:27
05/22/19
18:27
Periodicals
Spotify resets some users' passwords over 'suspicious activity,' TechCrunch says »

Spotify has informed an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXX

Idexx Laboratories

$250.45

1.24 (0.50%)

18:20
05/22/19
05/22
18:20
05/22/19
18:20
Hot Stocks
Idexx Laboratories CEO: We're at the beginning of our runway for growth »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

OMC

Omnicom

$79.79

-0.3 (-0.37%)

18:15
05/22/19
05/22
18:15
05/22/19
18:15
Hot Stocks
Omnicom CEO sells 60.5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$37.74

0.04 (0.11%)

18:12
05/22/19
05/22
18:12
05/22/19
18:12
Hot Stocks
Boston Scientific initiates trial of WATCHMAN FLX appendage closure platform »

Boston Scientific has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 26

    Jun

  • 13

    Nov

CTRP

Ctrip

$37.63

-0.24 (-0.63%)

18:03
05/22/19
05/22
18:03
05/22/19
18:03
Hot Stocks
Ctrip reports Q1 gross margin 79% vs. 82% a year ago »

Remained consistent with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

CTRP

Ctrip

$37.63

-0.24 (-0.63%)

18:02
05/22/19
05/22
18:02
05/22/19
18:02
Earnings
Breaking Earnings news story on Ctrip »

Ctrip sees Q2 net revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

CTRP

Ctrip

$37.63

-0.24 (-0.63%)

18:01
05/22/19
05/22
18:01
05/22/19
18:01
Earnings
Ctrip reports Q1 adjusted EPS 44c, consensus 24c »

Reports Q1 revenue $1.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

CE

Celanese

$100.10

-0.18 (-0.18%)

18:01
05/22/19
05/22
18:01
05/22/19
18:01
Hot Stocks
Celanese announces acetyls product price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRAY

Dentsply Sirona

$54.64

-0.25 (-0.46%)

17:57
05/22/19
05/22
17:57
05/22/19
17:57
Hot Stocks
Dentsply Sirona CFO Alexos to leave company in connection with relocation »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 05

    Jun

SIM

Grupo Simec

$9.23

(0.00%)

17:55
05/22/19
05/22
17:55
05/22/19
17:55
Hot Stocks
Grupo Simec receives noncompliance notification from NYSE »

Grupo Simec announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$64.78

-1.12 (-1.70%)

17:51
05/22/19
05/22
17:51
05/22/19
17:51
Earnings
Copart reports Q3 adjusted EPS 66c, consensus 62c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

NVS

Novartis

$83.94

1.555 (1.89%)

17:51
05/22/19
05/22
17:51
05/22/19
17:51
Periodicals
Novartis CEO sees Zolgensma price 'far lower' than $4M-$5M range, Reuters says »

Novartis CEO Vas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

PCG

PG&E

$19.00

0.55 (2.98%)

17:45
05/22/19
05/22
17:45
05/22/19
17:45
Periodicals
PG&E to remain in control of bankruptcy until September 29, WSJ reports »

PG&E will remain in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

OBLN

Obalon Therapeutics

$1.24

0.842 (211.56%)

17:41
05/22/19
05/22
17:41
05/22/19
17:41
Hot Stocks
Obalon Therapeutics discloses resignation of CEO »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GVA

Granite Construction

$41.37

-0.09 (-0.22%)

17:39
05/22/19
05/22
17:39
05/22/19
17:39
Hot Stocks
Granite Construction acquires additional trenchless rehabilitation assets »

Granite Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

NVCN

Neovasc

$0.48

-0.0023 (-0.48%)

17:36
05/22/19
05/22
17:36
05/22/19
17:36
Hot Stocks
Neovasc discloses International Journal of Cardiology review of Neovasc Reducer »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$285.61

-0.89 (-0.31%)

17:36
05/22/19
05/22
17:36
05/22/19
17:36
Periodicals
Pentagon mulls request to send 5,000 U.S. troops to Middle East, Reuters says »

The U.S. Department of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$285.61

-0.89 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$183.36

-0.52 (-0.28%)

17:35
05/22/19
05/22
17:35
05/22/19
17:35
Hot Stocks
Pool Corp. Chairman John Stokely sells almost $2M in company shares »

Pool Corp. Chairman John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 18

    Jun

  • 13

    Nov

RTN

Raytheon

$180.57

-2.05 (-1.12%)

17:35
05/22/19
05/22
17:35
05/22/19
17:35
Hot Stocks
Raytheon awarded $151.47M Navy contract for AIM-9X missile sustainment »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

ESV

Ensco Rowan

$10.01

-0.365 (-3.52%)

17:31
05/22/19
05/22
17:31
05/22/19
17:31
Hot Stocks
Ensco Rowan says will not pay a regular quarterly cash dividend »

Ensco Rowan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$171.29

1.67 (0.98%)

, GILD

Gilead

$66.51

-0.01 (-0.02%)

17:30
05/22/19
05/22
17:30
05/22/19
17:30
Upgrade
Amgen, Gilead, Alexion, Vertex, BioMarin, Biogen, Regeneron rating change  »

Citi assumes coverage of…

AMGN

Amgen

$171.29

1.67 (0.98%)

GILD

Gilead

$66.51

-0.01 (-0.02%)

ALXN

Alexion

$127.47

-1.33 (-1.03%)

VRTX

Vertex

$172.37

3.22 (1.90%)

BMRN

BioMarin

$87.80

0.33 (0.38%)

BIIB

Biogen

$234.98

2.04 (0.88%)

REGN

Regeneron

$320.00

10.19 (3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 31

    May

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 28

    Jun

BBX

BBX Capital

$4.95

-0.06 (-1.20%)

, BXG

Bluegreen Vacations

$14.91

-0.2 (-1.32%)

17:24
05/22/19
05/22
17:24
05/22/19
17:24
Hot Stocks
BBX Capital says will not proceed with merger with Bluegreen Vacations »

BBX Capital (BBX)…

BBX

BBX Capital

$4.95

-0.06 (-1.20%)

BXG

Bluegreen Vacations

$14.91

-0.2 (-1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

RTN

Raytheon

$180.57

-2.05 (-1.12%)

17:21
05/22/19
05/22
17:21
05/22/19
17:21
Hot Stocks
Raytheon awarded $234.64M Navy contract »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

WEX

Wex

$203.30

-1.56 (-0.76%)

17:20
05/22/19
05/22
17:20
05/22/19
17:20
Hot Stocks
Wex CEO sells 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.